Gainers

• Aethlon Medical (NASDAQ:AEMD) shares rose 330.8% to $6.16 during Thursday's regular session. The market value of their outstanding shares is at $1.0 million.
• bioAffinity Technologies (NASDAQ:BIAF) shares increased by 79.43% to $9.6. The market value of their outstanding shares is at $3.2 million.
• MediciNova (NASDAQ:MNOV) shares moved upwards by 36.09% to $3.43. The company's market cap stands at $124.0 million.
• Cypherpunk Technologies (NASDAQ:CYPH) stock rose 30.94% to $3.19. The market value of their outstanding shares is at $262.9 million.
• Lisata Therapeutics (NASDAQ:LSTA) shares moved upwards by 24.48% to $1.83. The market value of their outstanding shares is at $13.2 million.
• Nuwellis (NASDAQ:NUWE) stock moved upwards by 21.47% to $0.99. The company's market cap stands at $2.5 million.

Losers

• Longeveron (NASDAQ:LGVN) shares declined by 57.3% to $2.85 during Thursday's regular session. The company's market cap stands at $21.2 million.
• Tempest Therapeutics (NASDAQ:TPST) stock fell 25.99% to $0.9. The market value of their outstanding shares is at $20.0 million.
• Biodexa Pharmaceuticals (NASDAQ:BDRX) shares declined by 23.09% to $0.74. As per the press release, H1 earnings came out 4 days ago.
• DataMEDS AI (NASDAQ:MEDS) stock fell 20.93% to $4.8. The company's market cap stands at $18.5 million.
• Q/C Technologies (NASDAQ:QCLS) stock decreased by 18.87% to $0.78. The market value of their outstanding shares is at $7.8 million.
• Enlivex (NASDAQ:ENLV) stock decreased by 14.02% to $0.7. The market value of their outstanding shares is at $14.1 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.